Literature DB >> 29715478

Development of Novel Indole-3-Aldehyde-Loaded Gastro-Resistant Spray-Dried Microparticles for Postbiotic Small Intestine Local Delivery.

Matteo Puccetti1, Stefano Giovagnoli2, Teresa Zelante3, Luigina Romani3, Maurizio Ricci2.   

Abstract

Considering the recent evidence on the therapeutic potential of postbiotics, this study focused on 2 main goals: (1) to develop an enteric microparticle (MP) formulation for intestinal localized delivery of indole-3-aldehyde (3-IAld) (a microbial-derived metabolite produced by the host's lactobacilli during the catabolic pathway of tryptophan) and (2) to provide support in the employment of spray-drying as innovative one-step manufacturing technique for enteric products. For this purpose, special attention was taken in the knowledge of the influence of equipment setup and feedstock properties on MP enteric behavior. Eudragit® S100 and L100 and ethyl cellulose were used as wall materials and NaOH and ethanol solutions as solvent systems. 3-IAld loading was maintained at 10% w/w. As postulated, feedstock properties influenced spray-drying regime. In addition, they prevailed over other spray-drying process factors in determining MP enteric behavior. Albeit the high buckling regime that produced crumped particles, gastro resistance was obtained by spray-drying 2:1 Eudragit® S100:L100 with 30% w/w ethyl cellulose in ethanol solution. These results support the use of spray-drying as a method for manufacturing gastro-resistant MP. The obtained 3-IAld-loaded enteric MP will be useful to investigate novel postbiotic-based treatments in different therapeutic areas.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  controlled release; dissolution; drug delivery; microencapsulation; spray-drying

Mesh:

Substances:

Year:  2018        PMID: 29715478     DOI: 10.1016/j.xphs.2018.04.023

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Authors:  Seppo Salminen; Maria Carmen Collado; Akihito Endo; Colin Hill; Sarah Lebeer; Eamonn M M Quigley; Mary Ellen Sanders; Raanan Shamir; Jonathan R Swann; Hania Szajewska; Gabriel Vinderola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-04       Impact factor: 73.082

2.  Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.

Authors:  Giorgia Renga; Emilia Nunzi; Marilena Pariano; Matteo Puccetti; Marina Maria Bellet; Giuseppe Pieraccini; Fiorella D'Onofrio; Ilaria Santarelli; Claudia Stincardini; Franco Aversa; Francesca Riuzzi; Cinzia Antognelli; Marco Gargaro; Oxana Bereshchenko; Maurizio Ricci; Stefano Giovagnoli; Luigina Romani; Claudio Costantini
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

3.  Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model.

Authors:  Limin Xu; Bingdong Liu; Liujing Huang; Ze Li; Yanbo Cheng; Ye Tian; Guihua Pan; Huijun Li; Yinlan Xu; Weidong Wu; Zongbin Cui; Liwei Xie
Journal:  Microbiol Spectr       Date:  2022-06-22

Review 4.  Postbiotics: Current Trends in Food and Pharmaceutical Industry.

Authors:  Priyamvada Thorakkattu; Anandu Chandra Khanashyam; Kartik Shah; Karthik Sajith Babu; Anjaly Shanker Mundanat; Aiswariya Deliephan; Gitanjali S Deokar; Chalat Santivarangkna; Nilesh Prakash Nirmal
Journal:  Foods       Date:  2022-10-05

5.  Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis.

Authors:  Fiorella D'Onofrio; Giorgia Renga; Matteo Puccetti; Marilena Pariano; Marina Maria Bellet; Ilaria Santarelli; Claudia Stincardini; Paolo Mosci; Maurizio Ricci; Stefano Giovagnoli; Claudio Costantini; Luigina Romani
Journal:  Cells       Date:  2021-06-29       Impact factor: 6.600

6.  Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting.

Authors:  Matteo Puccetti; Marilena Pariano; Giorgia Renga; Ilaria Santarelli; Fiorella D'Onofrio; Marina M Bellet; Claudia Stincardini; Andrea Bartoli; Claudio Costantini; Luigina Romani; Maurizio Ricci; Stefano Giovagnoli
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.